Trial intelligence / Profile preview

Median effective concentration of propofol with different doses of dexmedetomidine during gastrointestinal endoscopy

ChiCTR2100054402Phase 4Recruiting

Sponsor
Shidong Hospital
Start
Dec 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of propofol in None (3 arms), sponsored by Shidong Hospital. Primary endpoints: Blood pressure and Heart rate. Started Dec 2021; status: recruiting.

02

Drugs

propofol

Beyond the preview

Go deeper on ChiCTR2100054402.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100054402.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call